- Home
- JYD vs HLVX Comparison
JYD vs HLVX Comparison
Compare JYD & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- HLVX
- Stock Information
- Founded
- JYD 2001
- HLVX 2020
- Country
- JYD China
- HLVX United States
- Employees
- JYD N/A
- HLVX N/A
- Industry
- JYD Oil Refining/Marketing
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- JYD Consumer Discretionary
- HLVX Health Care
- Exchange
- JYD Nasdaq
- HLVX Nasdaq
- Market Cap
- JYD 87.4M
- HLVX 92.6M
- IPO Year
- JYD 2023
- HLVX 2022
- Fundamental
- Price
- JYD $1.99
- HLVX $1.86
- Analyst Decision
- JYD
- HLVX Hold
- Analyst Count
- JYD 0
- HLVX 5
- Target Price
- JYD N/A
- HLVX $2.33
- AVG Volume (30 Days)
- JYD 3.1M
- HLVX 317.3K
- Earning Date
- JYD 01-03-2025
- HLVX 11-07-2024
- Dividend Yield
- JYD N/A
- HLVX N/A
- EPS Growth
- JYD N/A
- HLVX N/A
- EPS
- JYD N/A
- HLVX N/A
- Revenue
- JYD $82,427,232.00
- HLVX N/A
- Revenue This Year
- JYD N/A
- HLVX N/A
- Revenue Next Year
- JYD N/A
- HLVX N/A
- P/E Ratio
- JYD N/A
- HLVX N/A
- Revenue Growth
- JYD 63.05
- HLVX N/A
- 52 Week Low
- JYD $0.42
- HLVX $1.55
- 52 Week High
- JYD $2.83
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- JYD 63.81
- HLVX 44.78
- Support Level
- JYD $1.69
- HLVX $1.95
- Resistance Level
- JYD $2.00
- HLVX $1.97
- Average True Range (ATR)
- JYD 0.38
- HLVX 0.07
- MACD
- JYD 0.02
- HLVX -0.02
- Stochastic Oscillator
- JYD 76.92
- HLVX 10.00
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is a end-to-end supply chain solution providers in China, with a focus on providing cross-border logistics services. It offers freight forwarding services, (ii) supply chain management, and (iii) other value-added services.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.